4Grekas D, Balaskas E, Kampouris H, et al. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage [ J ]. Clin Nephrol, 1999, 52 ( 3 ) : 167-171.
5Martin KJ, Gonzalez E, Lindberg JS, et al. Paricalcitol dosing according to body weight or severity of hyperparathyroidism: a double-blind,multicenter, randomized study [J]. Am J Kidney Dis, 2001,38 ( 5 Suppl 5) : S57-63.
6Cuppari L, Carvalho AB, Lobao RR, et al. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease [J]. Clin Nephrol, 2001,56 ( 1 ) : 35-43.
7Zhou X, Loke KY, Pillai CC, et al. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH [ J ]. Eur J Endocrinol, 2001,144 ( 3 ) : 237-243.
8Bryant J, Cave C, Mihaylova B, et al. Clinical effectiveness and cesteffectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation [J]. Health Technol Assess, 2002,6 (19):1-106.
9Fine RN, Stablein D, Cohen AH, et al. Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS[ J]. Kidney Int, 2002,62(2) : 688-696.
10Norman IJ, Coleman JE, Macdonald IA, et al. Nutrition and growth in relation to severity of renal disease in children [ J ]. Pediatr Nephrol,2000.15(3-4) :259-265.
4Churg J, Sobin LH. Renal disease - classification and at 1as of glomerula disease. Tokyo: lgaku. Shoin Medical Publishs Inc, 1982.4 - 5.
5Churg J, Bemstein J, Glassock RJ. Renal disease - Classification and at las of glomerula disease, second edition. New York: Igaku -shoin Medical Publishs Inc, 1995.4-5.
